Biostone Achieves MDSAP Certification
In January of this year, Biostone was delighted to receive MDSAP certification from BSI.
In January of this year, Biostone was delighted to receive MDSAP certification from BSI.
Biostone sincerely invites you to visit us at the AAOS 2023 Annual Meeting at Booth 5945 from March 8th-10th.
In October, Biostone returned to Chicago’s McCormick Place for this years’ NASS Annual Meeting.
It’s so good to see you again in Chicago! Biostone will be in Chicago from 12th to 14th October 2022 to participate in the…
Biostone will be at the AAOS Exhibition 2022! This year, AAOS will be at McCormick Place, South Building, in Chicago. You are welcome to…
In April of this year, Biostone were delighted to find out that they had received US FDA 510K clearance for their first bone graft…
Biostone was established in 2017 by Dr Wei-Jen Lo at BioCity of Nottingham, UK. The aim of the company is to utilise a proprietary technology to create a new line of synthetic bone graft products to improve the clinical outcome and life quality for the patient
Copyright © 2025 Biostone Co. Ltd.